1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Exosome Therapeutics Market Outlook
4.1.
Market Size &
Forecast
4.1.1.
By Value
4.2.
Market Share &
Forecast
4.2.1.
By Exosome Type (Natural,
Hybrid)
4.2.2.
By Source (Mesenchymal Stem Cells, Blood, Body Fluids,
Others)
4.2.3.
By Therapy (Immunotherapy, Chemotherapy, Gene Therapy)
4.2.4.
By Application (Metabolic Disorders, Oncology, Cardiac
Disorders, Neurology, Others)
4.2.5.
By End User (Hospitals & Clinics, Academic &
Research Institutions, Others)
4.2.6.
By Region
4.2.7.
By Company (2023)
4.3.
Market Map
4.3.1.
By Exosome Type
4.3.2.
By Source
4.3.3.
By Therapy
4.3.4.
By Application
4.3.5.
By End User
4.3.6.
By Region
5. Asia Pacific Exosome Therapeutics Market Outlook
5.1.
Market Size &
Forecast
5.1.1.
By Value
5.2.
Market Share &
Forecast
5.2.1.
By Exosome Type
5.2.2. By Source
5.2.3.
By Therapy
5.2.4.
By Application
5.2.5.
By End User
5.2.6.
By Country
5.3.
Asia Pacific:
Country Analysis
5.3.1.
China Exosome
Therapeutics Market Outlook
5.3.1.1.
Market Size & Forecast
5.3.1.1.1.
By Value
5.3.1.2.
Market Share & Forecast
5.3.1.2.1.
By Exosome Type
5.3.1.2.2.
By Source
5.3.1.2.3.
By Therapy
5.3.1.2.4.
By Application
5.3.1.2.5.
By End User
5.3.2.
India Exosome
Therapeutics Market Outlook
5.3.2.1.
Market Size & Forecast
5.3.2.1.1.
By Value
5.3.2.2.
Market Share & Forecast
5.3.2.2.1.
By Exosome Type
5.3.2.2.2.
By Source
5.3.2.2.3.
By Therapy
5.3.2.2.4.
By Application
5.3.2.2.5.
By End User
5.3.3.
Australia Exosome
Therapeutics Market Outlook
5.3.3.1.
Market Size & Forecast
5.3.3.1.1.
By Value
5.3.3.2.
Market Share & Forecast
5.3.3.2.1.
By Exosome Type
5.3.3.2.2.
By Source
5.3.3.2.3.
By Therapy
5.3.3.2.4.
By Application
5.3.3.2.5.
By End User
5.3.4.
Japan Exosome
Therapeutics Market Outlook
5.3.4.1.
Market Size & Forecast
5.3.4.1.1.
By Value
5.3.4.2.
Market Share & Forecast
5.3.4.2.1.
By Exosome Type
5.3.4.2.2.
By Source
5.3.4.2.3.
By Therapy
5.3.4.2.4.
By Application
5.3.4.2.5.
By End User
5.3.5.
South Korea Exosome Therapeutics
Market Outlook
5.3.5.1.
Market Size & Forecast
5.3.5.1.1.
By Value
5.3.5.2.
Market Share & Forecast
5.3.5.2.1.
By Exosome Type
5.3.5.2.2.
By Source
5.3.5.2.3.
By Therapy
5.3.5.2.4.
By Application
5.3.5.2.5.
By End User
6. Europe Exosome Therapeutics Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1. By Exosome Type
6.2.2.
By Source
6.2.3.
By Therapy
6.2.4.
By Application
6.2.5.
By End User
6.2.6. By Country
6.3.
Europe: Country
Analysis
6.3.1.
France Exosome
Therapeutics Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Exosome Type
6.3.1.2.2.
By Source
6.3.1.2.3.
By Therapy
6.3.1.2.4.
By Application
6.3.1.2.5.
By End User
6.3.2.
Germany Exosome
Therapeutics Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Exosome Type
6.3.2.2.2.
By Source
6.3.2.2.3.
By Therapy
6.3.2.2.4.
By Application
6.3.2.2.5.
By End User
6.3.3.
Spain Exosome
Therapeutics Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Exosome Type
6.3.3.2.2.
By Source
6.3.3.2.3.
By Therapy
6.3.3.2.4.
By Application
6.3.3.2.5.
By End User
6.3.4.
Italy Exosome
Therapeutics Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Exosome Type
6.3.4.2.2.
By Source
6.3.4.2.3.
By Therapy
6.3.4.2.4.
By Application
6.3.4.2.5.
By End User
6.3.5.
United Kingdom Exosome
Therapeutics Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Exosome Type
6.3.5.2.2.
By Source
6.3.5.2.3.
By Therapy
6.3.5.2.4.
By Application
6.3.5.2.5.
By End User
7. North America Exosome Therapeutics Market Outlook
7.1.
Market Size &
Forecast
7.1.1.
By Value
7.2.
Market Share &
Forecast
7.2.1.
By Exosome Type
7.2.2.
By Source
7.2.3.
By Therapy
7.2.4.
By Application
7.2.5.
By End User
7.2.6.
By Country
7.3.
North America:
Country Analysis
7.3.1.
United States Exosome
Therapeutics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Exosome Type
7.3.1.2.2.
By Source
7.3.1.2.3.
By Therapy
7.3.1.2.4.
By Application
7.3.1.2.5.
By End User
7.3.2.
Mexico Exosome
Therapeutics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Exosome Type
7.3.2.2.2.
By Source
7.3.2.2.3.
By Therapy
7.3.2.2.4.
By Application
7.3.2.2.5.
By End User
7.3.3.
Canada Exosome
Therapeutics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Exosome Type
7.3.3.2.2.
By Source
7.3.3.2.3.
By Therapy
7.3.3.2.4.
By Application
7.3.3.2.5.
By End User
8. South America Exosome Therapeutics Market Outlook
8.1.
Market Size &
Forecast
8.1.1.
By Value
8.2.
Market Share &
Forecast
8.2.1.
By Exosome Type
8.2.2.
By Source
8.2.3.
By Therapy
8.2.4.
By Application
8.2.5.
By End User
8.2.6.
By Country
8.3.
South America:
Country Analysis
8.3.1.
Brazil Exosome
Therapeutics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Exosome Type
8.3.1.2.2.
By Source
8.3.1.2.3.
By Therapy
8.3.1.2.4.
By Application
8.3.1.2.5.
By End User
8.3.2.
Argentina Exosome
Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Exosome Type
8.3.2.2.2.
By Source
8.3.2.2.3.
By Therapy
8.3.2.2.4.
By Application
8.3.2.2.5.
By End User
8.3.3.
Colombia Exosome
Therapeutics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Exosome Type
8.3.3.2.2.
By Source
8.3.3.2.3.
By Therapy
8.3.3.2.4.
By Application
8.3.3.2.5.
By End User
9. Middle East and Africa Exosome Therapeutics Market
Outlook
9.1.
Market Size &
Forecast
9.1.1.
By Value
9.2.
Market Share &
Forecast
9.2.1.
By Exosome Type
9.2.2.
By Source
9.2.3.
By Therapy
9.2.4.
By Application
9.2.5.
By End User
9.2.6.
By Country
9.3.
MEA: Country
Analysis
9.3.1.
South Africa Exosome
Therapeutics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Exosome Type
9.3.1.2.2.
By Source
9.3.1.2.3.
By Therapy
9.3.1.2.4.
By Application
9.3.1.2.5.
By End User
9.3.2.
Saudi Arabia Exosome
Therapeutics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Exosome Type
9.3.2.2.2.
By Source
9.3.2.2.3.
By Therapy
9.3.2.2.4.
By Application
9.3.2.2.5.
By End User
9.3.3.
UAE Exosome
Therapeutics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Exosome Type
9.3.3.2.2.
By Source
9.3.3.2.3.
By Therapy
9.3.3.2.4.
By Application
9.3.3.2.5.
By End User
10.
Market Dynamics
10.1.
Drivers
10.2.
Challenges
11.
Market Trends &
Developments
11.1.
Recent Developments
11.2.
Product Launches
11.3.
Mergers &
Acquisitions
12.
Global Exosome
Therapeutics Market: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New
Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Product
14.
Competitive
Landscape
14.1. Aethlon Medical, Inc
14.1.1.
Business Overview
14.1.2.
Company Snapshot
14.1.3.
Product & Services
14.1.4.
Financials (In case
of listed)
14.1.5.
Recent Developments
14.1.6.
SWOT Analysis
14.2.
AEGLE
Therapeutics Corporation
14.3.
Anjarium Biosciences
AG
14.4.
Exogenus
Therapeutics SA
14.5.
Lonza Group AG
14.6.
Capricor
Therapeutics, Inc
14.7.
Avalon GloboCare
Corp.
14.8.
Stem Cell Medicine
Ltd.
14.9.
Evox Therapeutics
Limited
14.10.EV Therapeutics
15.
Strategic Recommendations
16. About
Us & Disclaimer